Opaganib is a selective platelet-derived growth factor receptor (PDGFR) inhibitor utilized in research as an anti-angiogenic agent for treating various solid tumors, including glioblastoma, renal cell… Read more
Opaganib is a selective platelet-derived growth factor receptor (PDGFR) inhibitor utilized in research as an anti-angiogenic agent for treating various solid tumors, including glioblastoma, renal cell carcinoma, and hepatocellular carcinoma. This category provides essential pharmaceutical reference standards required for rigorous analytical testing and quality control of this therapeutic compound. Laboratories rely on these high-quality materials, including impurities such as Opaganib N-Oxide and stable isotope labelled compounds like Opaganib-d4, to support accurate impurity profiling and metabolite identification. By utilizing these characterized reference standards, researchers can perform precise method validation and quantification, ensuring the reliability of data throughout the drug development lifecycle. These specialized products are indispensable tools for maintaining compliance with regulatory standards in the analysis of Opaganib and its related derivatives in complex matrices.